This journal publishes research on the development and evaluation of novel cancer therapeutics, including small-molecule inhibitors, antibody-drug conjugates (ADCs), and bispecific ADCs. Studies focus on identifying therapeutic targets, understanding mechanisms of drug resistance, and assessing the efficacy of new agents in preclinical models and early clinical trials. The research also explores the role of the tumor microenvironment and immune responses in cancer treatment.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Cancer ResearchQ1
OncologyQ1
Subject Classification
Web of Science Categories
Oncology
Scopus Categories
Cancer ResearchOncology
Research Topics (OpenAlex)
Cancer, Hypoxia, and MetabolismCancer-related Molecular PathwaysMonoclonal and Polyclonal Antibodies ResearchCancer Genomics and DiagnosticsHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsCancer Research and TreatmentsPI3K/AKT/mTOR signaling in cancerUbiquitin and proteasome pathwaysProtein Degradation and Inhibitors